6 Results

BD issues statement on FDA relating to paclitaxel-coated devices and long term mortality

 Added 3 days ago

BD (Becton, Dickinson and Company) issued the following statement related to the recent letter from FDA to health care providers...

Positive trial data for Lutonix 014 Drug-Coated Balloon to treat narrowed or obstructed arteries below the knee. Becton Dickinson

 Added 4 months ago

BD (Becton, Dickinson and Company) announced the safety and efficacy data from the Lutonix Drug-Coated Balloon (DCB) IDE, level 1...

REX 001 enters Phase III trials as a treatment for critical limb ischaemia.- Rexgenero Ltd.

 Added 1 year ago

Rexgenero Ltd, a clinical-stage regenerative medicine company developing advanced cell-based therapies with a focus on Critical Limb Ischemia (CLI), announces...

FDA approves Sentinel Cerebral Protection System to protect against risk of stroke during TAVR procedures.- Claret Medical

 Added 1 year ago

Claret Medical announced that it has received regulatory clearance from the FDA for the Sentinel Cerebral Protection System (CPS), via...

International Society on Thrombosis and Hemostasis (ISTH) announce upcoming Berlin congress

 Added 1 year ago

The International Society on Thrombosis and Haemostasis (ISTH) today announced its upcoming ISTH 2017 Congress is expected to surpass its own records.


Trial of Sentinel Cerebral Protection System meets primary endpoint in TAVR- Claret Medical

 Added 2 years ago

Claret Medical has announced the results from the SENTINEL pivotal IDE trial of the Sentinel Cerebral Protection System (CPS), used...